Skye Bioscience, Inc. - Common Stock (SKYE)

Skye Bioscience Inc. is a biotechnology company focused on the development of innovative therapeutics derived from cannabis

The company leverages its expertise in cannabinoid research to create new treatment options targeting various medical conditions, with a particular emphasis on addressing unmet needs in the fields of pain management and ocular diseases. By harnessing the potential of cannabinoid compounds, Skye aims to enhance patients' quality of life through breakthrough therapies that utilize natural plant-based ingredients. The company's mission revolves around advancing scientific understanding and unlocking the therapeutic benefits of cannabis to improve health outcomes.